Guillain-Barré syndrome (GBS)

Clinical trials for Guillain-Barré syndrome (GBS) explained in plain language.

Never miss a new study

Get alerted when new Guillain-Barré syndrome (GBS) trials appear

Sign up with your email to follow new studies for Guillain-Barré syndrome (GBS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet recruiting 1

Can a second antibody drug help Guillain-Barré patients walk again sooner?

Disease control Not yet recruiting

Guillain-Barré syndrome (GBS) is a rare condition where the immune system attacks nerves, causing weakness that can progress to paralysis. Standard treatment is intravenous immunoglobulin (IVIg), but recovery is often slow. This phase 2 trial tests whether adding an experimental …

Matched conditions: GUILLAIN-BARRÉ SYNDROME (GBS)

Phase 2 • Sponsor: argenx • Aim: Disease control

Last updated Sep 18, 2026 00:00 UTC

Guillain-Barré syndrome (GBS)

Get alerted when new Guillain-Barré syndrome (GBS) trials appear

Can a second antibody drug help Guillain-Barré patients walk again sooner?